Elevated RGMA Expression Predicts Poor Prognosis in Patients with Glioblastoma.

Onco Targets Ther

Department of Animal Science, College of Agriculture and Life Sciences, Chonnam National University, Gwangju, 61186, Republic of Korea.

Published: September 2021

Background: Glioblastoma (GBM) is the most aggressive type of human brain tumor with a poor prognosis and a low survival rate. Secreted proteins from tumors are recently considered as important modulators to promote tumorigenesis by communicating with microenvironments. Repulsive guidance molecule A (RGMA) was initially characterized as an axon guidance molecule after secretion in the brain during embryogenesis but has not been studied in GBM. In this study, we investigated secreted gene expression patterns and the correlation between RGMA expression and prognosis in GBM using in silico analysis.

Methods: mRNA levels in normal human astrocyte (NHA), human glioma cells, and GBM patient-derived glioma stem cells (GSCs) were assessed by qRT-PCR. Patient survival analysis was performed with the Kaplan-Meier curve and univariate and multivariate analyses using publicly available datasets. The predictive roles of RGMA in progressive malignancy were evaluated using Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Gene Set Enrichment Analysis (GSEA).

Results: mRNA expression was elevated in glioma cells and GSCs compared with NHA and correlated with unfavorable prognosis in glioma patients. Thus, RGMA could serve as an independent predictive factor for GBM. Furthermore, the increased levels of RGMA expression and its putative receptor, neogenin (NEO1), were associated with poor patient survival rates in GBM.

Conclusion: We identified RGMA as an independent prognostic biomarker for progressive malignancy in glioblastoma and address the possibilities to develop novel therapeutic strategies against glioblastoma.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473061PMC
http://dx.doi.org/10.2147/OTT.S317285DOI Listing

Publication Analysis

Top Keywords

rgma expression
12
poor prognosis
8
guidance molecule
8
glioma cells
8
cells gscs
8
patient survival
8
progressive malignancy
8
rgma
6
expression
5
gbm
5

Similar Publications

Genetics of constant and severe pain in the NAPS2 cohort of recurrent acute and chronic pancreatitis patients.

J Pain

December 2024

Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA; Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA; Department of Neurobiology, Pittsburgh Center for Pain Research, University of Pittsburgh, Pittsburgh, PA, USA; Department of Cell Biology & Molecular Physiology, University of Pittsburgh, Pittsburgh, PA, USA. Electronic address:

Recurrent acute and chronic pancreatitis (RAP, CP) are complex, progressive inflammatory diseases with variable pain experiences impacting patient function and quality of life. The genetic variants and pain pathways in patients contributing to most severe pain experiences are unknown. We used previously genotyped individuals with RAP/CP from the North American Pancreatitis Study II (NAPS2) of European Ancestry for nested genome-wide associated study (GWAS) for pain-severity, chronicity, or both.

View Article and Find Full Text PDF

This study is to explore the effects of paeoniflorin (PF) on oxidative stress (OS) and inflammation in Parkinson's disease (PD) via the HSF1-NRF1 axis. SH-SY5Y cells were pretreated with PF and induced with α-synuclein preformed fibrils (PFF), followed by gain- and loss-of-function assays. Afterward, detection was conducted on cell viability, mitochondrial membrane potential ([Formula: see text]m), and reactive oxygen species (ROS), cyclooxygenase (COX)-2, and inducible nitric oxide synthase (iNOS) levels.

View Article and Find Full Text PDF

Objective: Spinal cord injury (SCI) is a debilitating condition that often results in paralysis and lifelong medical challenges. Research has shown that epigenetic modifications, particularly histone acetylation, play a role in neuroprotection following hypoxic-ischemic events in SCI. The objective of this study was to explore the effects of histone H3K27 acetylation, along with its underlying mechanisms, on the tolerance to hypoxia and ischemia in SCI.

View Article and Find Full Text PDF

Anti-RGMa neutralizing antibody ameliorates vascular cognitive impairment in mice.

Neurotherapeutics

November 2024

Department of Molecular Neuroscience, Graduate School of Medicine, Osaka University, Suita, Japan; Department of Neuro-Medical Science, Graduate School of Medicine, Osaka University, Suita, Japan; WPI-Immunology Frontier Research Center, Osaka University, Suita, Japan. Electronic address:

Article Synopsis
  • Repulsive Guidance Molecule A (RGMa) is important for guiding nerve connections and has shown various functions in brain diseases like spinal cord injury and Parkinson's disease.
  • In this study, RGMa's role was investigated in a mouse model of vascular dementia (VaD), where it was found to be overexpressed in the hippocampus, leading to cognitive decline.
  • Treatment with an anti-RGMa neutralizing antibody not only improved cognitive function but also reversed the negative effects of RGMa on neurogenesis and cholinergic innervation, indicating a potential new treatment for VaD.
View Article and Find Full Text PDF
Article Synopsis
  • Herpetospermum pedunculosum (HP), a traditional Tibetan herb, has shown potential in modern studies for treating liver damage, specifically in alleviating nonalcoholic fatty liver disease (NAFLD) through its lignan-rich extract (EAHP).
  • In an experiment using a mouse model of NAFLD, researchers evaluated EAHP's effects, finding significant improvements in liver health indicators, such as reduced liver size and liver damage markers in the serum, as well as better lipid metabolism.
  • Chemical analysis identified 36 compounds in EAHP, and further research indicated it regulates lipid abnormalities and inflammatory responses, showing promise for therapeutic use in liver-related diseases.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!